Want to see TECH full AI Analyst Report?
Operating Income by Segment
Reports each segment’s profit after operating costs, revealing which parts of the business cover their overhead and contribute to core profitability. Tracking these trends shows whether growth is coming from efficient, scalable operations or from lower-margin areas that may need restructuring.Protein Sciences' operating income shows consistent seasonality—repeated strong Q1 peaks and recurring Q3 troughs—while peak Q1s have crept higher through 2025–26, but Q3 lows have deepened, producing lumpy quarterly results. That pattern suggests demand tied to funding/ordering cycles rather than structural margin expansion; expect full-year stability but volatile quarter-to-quarter guidance risk. Investors should prioritize year-over-year and trailing-12-month trends and management commentary on order visibility rather than any single quarter.
Date | Protein Sciences |
|---|---|
Jun 30, 2026 | $97.07M |
Mar 31, 2026 | $100.00M |
Dec 31, 2025 | $84.61M |
Sep 30, 2025 | $77.71M |
Jun 30, 2025 | $98.79M |
Mar 31, 2025 | $103.91M |
Dec 31, 2024 | $87.11M |
Sep 30, 2024 | $80.54M |
Jun 30, 2024 | $92.00M |
Mar 31, 2024 | $94.83M |